|  Help  |  About  |  Contact Us

Publication : p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia.

First Author  Saiz-Ladera C Year  2014
Journal  Oncogene Volume  33
Issue  37 Pages  4599-4612
PubMed ID  24121270 Mgi Jnum  J:214350
Mgi Id  MGI:5588792 Doi  10.1038/onc.2013.417
Citation  Saiz-Ladera C, et al. (2014) p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia. Oncogene 33(37):4599-612
abstractText  The retinoblastoma gene product (pRb) controls proliferation and differentiation processes in stratified epithelia. Importantly, and in contrast to other tissues, Rb deficiency does not lead to spontaneous skin tumor formation. As the cyclin-dependent kinase inhibitor p21 regulates proliferation and differentiation in the absence of pRb, we analyzed the consequences of deleting p21 in pRb-ablated stratified epithelia (hereafter pRb(DeltaEpi);p21-/-). These mice display an enhancement of the phenotypic abnormalities observed in pRb(DeltaEpi) animals, indicating that p21 partially compensates pRb absence. Remarkably, pRb(DeltaEpi);p21-/- mice show an acute skin inflammatory phenotype and develop spontaneous epithelial tumors, particularly affecting tongue and oral tissues. Biochemical analyses and transcriptome studies reveal changes affecting multiple pathways, including DNA damage and p53-dependent signaling responses. Comparative metagenomic analyses, together with the histopathological profiles, indicate that these mice constitute a faithful model for human head and neck squamous cell carcinomas. Collectively, our findings demonstrate that p21, in conjunction with pRb, has a central role in regulating multiple epithelial processes and orchestrating specific tumor suppressor functions.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

Trail: Publication

0 Expression